Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

RNARNA
2 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ATRIUM THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 310,341 shares of RNA (ATRIUM THERAPEUTICS INC), worth $4.2M as of 2026-Q2. The position was decreased (-11.3% shares). RNA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$4.2M

Current Shares

310,341

Total Value Change

-$504,745

Total Shares Change

-39,609

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
310,341
-11.3%
$4.2M0.0%$13.45
0
2026-Q1
New
349,950
-
$4.7M0.0%$15.67
37

Other major holders of RNA: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used